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Objective: Congenital dislocation of the hip (CDH) is a multifactorial disease which involves genetic
factors that are still unidentiﬁed. Recently, a functional polymorphism (rs143383) of the 50-untranslated
region of GDF5 (Growth/Differentiation Factor 5) e previously reported to be associated with osteoar-
thritis e has been associated with CDH in a Chinese population. The aim of our study was to determine
whether GDF5, known to be involved in bone, joint and cartilage morphogenesis, is also associated with
CDH in Caucasians.
Design: We genotyped three tagSNPs (rs224334, rs143384, rs143383) in 239 cases and 239 controls from
western Brittany (France) where CDH is frequent, and tested the association using both single-locus and
haplotype-based approaches.
Results: The most signiﬁcant association was observed with rs143384. The T allele of this SNP was
overrepresented in cases (65.9% vs 55.9%, P¼ 0.002). Under a recessive model, carriers of the TT genotype
had a 1.71-fold higher risk of developing CDH than carriers of the other genotypes (ORTT vs CTþCC¼ 1.71,
95% CI: [1.18e2.48], P¼ 0.005). At a nominal level, the association was also signiﬁcant with rs143383
(ORTT vs CTþCC¼ 1.52, 95% CI: [1.05e2.19], P¼ 0.026). The haplotype carrying the susceptibility alleles of
these SNPs was also more frequent in cases (65.9% vs 55.9%, OR¼ 1.53, 95% CI: [1.18e1.98], P¼ 0.002).
Conclusion: This study reports, for the ﬁrst time, the association between GDF5 polymorphisms and CDH
in Caucasians, and points out another polymorphism of interest that requires further investigation.
Reduction in GDF5 expression might lead to developmental deﬁciency of ligaments and capsule in hip
joint, and therefore contribute to CDH pathogenesis.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
With an incidence of 1e10 newborns in 1000 in Caucasians,
congenital dislocation of the hip [CDH e OMIM:142700] is one of
the most common congenital skeletal disorders. It is characterised
by an abnormal seating of the femoral head in the acetabulum1,2.Virginie Scotet, Inserm U613,
, France. Tel: 33-2-98-44-50-
otet).
work.
s Research Society International. PThis condition is a public health matter because of its high
frequency and its natural evolution towards hip osteoarthritis,
which is a major concern for ageing societies worldwide3.
CDH is considered as a multifactorial disease and includes, on
the one hand, a mechanical component related to pregnancy and
delivery conditions, and on the other hand, a genetic component
evidenced by familial aggregation and twin studies. Higher recur-
rence risks of CDH have been reported in ﬁrst-degree relatives
(siblings: l¼ 12)4e6, as well as a higher concordance in mono-
zygotic than in dizygotic twins (40% vs 3%)7. This genetic predis-
position has been reported to be linked to acetabulum shallowness
or capsular joint laxity8e10.ublished by Elsevier Ltd. All rights reserved.
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involved in CDH. However, Dai et al. reported in 2008 a signiﬁcant
association between CDH and a functional polymorphism
(rs143383) of the 50-untranslated region (50-UTR) of GDF5 (Growth/
Differentiation Factor 5) in a Chinese population11. This poly-
morphism was previously found to be associated with osteoar-
thritis12. This associationwith osteoarthritis has subsequently been
widely replicated13e17 and further supported by functional
evidence13,18, making GDF5 an interesting susceptibility gene for
that disease.
GDF5 is known to play a key role in bone and cartilage
morphogenesis as well as in joint formation19e21. The protein
encoded by this gene belongs to the transforming growth factor-b
(TGF-b) superfamily and is closely related to the bone morphoge-
netic proteins (BMPs) subfamily22. In humans, mutations in GDF5
have been associated with a broad spectrum of skeletal disorders,
including various types of chondrodysplasia and limb malforma-
tions (proximal symphalangism and brachydactyly type C)23e26. It
should be noted that some of the patients with brachydactyly type
C also present hip joint dysplasia27. Moreover, it has also been
shown that, in mice, a functional null mutation in GDF5was able to
induce developmental failure of the intra-articular ligaments28,29.
Regarding pathophysiology, decrease in GDF5 expression might
induce developmental deﬁciency of ligaments and capsule in hip
joints, and/or might affect acetabulum morphology, therefore
contributing to CDH pathogenesis. The aim of our study was to
determine whether GDF5 is associated with CDH in a Caucasian
population. For that, we carried out a more complete analysis of the
gene based on linkage disequilibrium (LD) information and used
both single-locus and haplotype-based approaches.
Method
Study population
CDH is particularly frequent in our area (Finistère, western
Brittany, France), especially in a speciﬁc district called “Pays Big-
ouden” where the incidence has been estimated as 38/100030. The
present study relies on a case-control association study set up in
our area, which includes 239 CDH unrelated patients and 239
healthy individuals. As previously described31, the affected indi-
viduals were mainly selected by expert surgeons through the main
centres involved in the screening and treatment of CDH in Finistère
(Hospitals of Brest, Pont L’Abbé, Quimper and Roscoff). The diag-
nosis of CDHwas made on the basis of clinical criteria in addition to
ultrasound and/or radiographic evidence. Cases included in this
study corresponded, for newborns, to grades III and IV of the
sonographic classiﬁcation of Graf and Wilson32, and for adults, to
VCE angle< 20 (i.e., vertical centre edge or Wiberg angle) and HTE
angle> 12 (i.e., horizontal toit externe or Tönnis angle). Adult
patients were all diagnosed in infancy and followed from that time.
The control group was matched for gender, age and ethnic
origin. For children, controls were selected among patients
consulting in one of the paediatric study centres for one other
medical reason than hip disorders. For adults, controls were
selected among patients consulting in one of the participating
centres or among blood donors from the same area. Control indi-
viduals did not present hip disorders and had no positive family
history of CDH.
The blood samples collected were prepared in accordance with
usual procedures and a salting-out method was used to extract
DNA.
This research program was approved by the ethical committee
of Brest University Hospital (approval no. 3.358-A). All participants
gave written informed consent to take part in the study.Selection and genotyping of polymorphisms
GDF5 is located on chromosome 20 at position 20q11.2. It
contains two exons and covers a region of 4878 base pairs. In order
to study the role of this gene, we selected a set of informative single
nucleotide polymorphisms (called tagSNPs), using the Tagger
software (http://www.broad.mit.edu/mpg/tagger/)33, which
implements data of the HapMap Project34e37. This selection was
made in reference to the Caucasian population (CEU population), by
considering a minor allele frequency 0.05 and a pairwise r2
threshold of 0.80. This analysis led to the selection of three tagSNPs:
rs224334 (A/G) (located in the intron 1), rs143384 (C/T) and
rs143383 (C/T) (both located in the 50-UTR region). The functional
polymorphism rs143383 was therefore captured by this selection.
The SNPs were genotyped in our laboratory by an allelic
discrimination technique (SNaPshot) using an ABI Prism 3130xl
instrument (Applied Biosystems, Inc.). Genotyping was successful
for all markers in the whole sample.
Statistical analysis
Initially, we tested departure from HardyeWeinberg equilib-
rium (HWE) for each SNP using Finetti software (http://ihg2.
helmholtzmuenchen.de/cgibin/hw/hwa1.pl).
Later on, we analysed data using both single-locus and haplo-
type-based approaches. In a ﬁrst step, we tested individually the
association between each marker and CDH using SAS software
(version 9.1 e SAS Institute, Cary, NC, USA). The genotype and allele
distributions were compared in cases and controls using the c2 test.
In order to estimate the strength and precision of the associations,
odds-ratios (ORs)with their 95% conﬁdence intervals (95% CIs)were
computed using logistic regression models. The various modes of
transmission (dominant, recessive andadditive)were tested foreach
SNPandtheBonferroni correctionwasapplied inorder toaccount for
multiple testing. In a second step,wecarriedout ahaplotypeanalysis
using Haploview software (v4.0, http://www.broad.mit.edu/mpg/
haploview/)38, which visualises the structure of pairwise LD
between markers and infers haplotypes. Haplotype frequencies
were estimated from genotyping data using the stochastic expec-
tation-maximisation algorithm and compared using the c2 test.
Finally, in order to ensure that our study achieved sufﬁcient
power, we performed power calculations using PGA software, by
assuming a disease prevalence of 38/100039.
Results
Allele frequencies
As mentioned above, the three SNPs (rs224334, rs143384,
rs143383) were successfully genotyped in the 239 cases and 239
controls. Frequencies of the major alleles of these markers (i.e., G, T,
T) were respectively 95.6%, 55.9% and 61.3% in the control group. As
illustrated in Table I, the genotype frequencies conformed to those
expected under HWE and were also consistent with those observed
in the HapMap database for Caucasians. It should nevertheless be
noted that allele frequencies of rs143383 (i.e., the single SNP
studied by Dai et al.11) differed between our population and Han
Chinese. The T allele of this marker appeared signiﬁcantly less
frequent in our population (61.3% vs 73.8%, P< 0.0001).
Single-locus association study
At a nominal signiﬁcance level, two of the three studied SNPs
were found to be associated with CDH: rs143383 and rs143384
(Table II).
Table I
Comparison of allelic frequencies between our study and the HapMap database (CEU
population) and test of deviation from HWE for each SNP
SNP Major
allele
Major allele frequency (%)
Our study HapMap database Study of Dai et al. HWE (P)
1 2 3
rs224334
(A/G)
G 95.6 96.7 e 0.477
rs143384
(C/T)
T 55.9 60.0 e 0.708
rs143383
(C/T)
T 61.3 66.7 73.8 0.445
Comparison 1 vs 2: P¼ 0.406, P¼ 0.209 and P¼ 0.080, respectively; Comparison 1 vs
3: P< 0.0001; Comparison 2 vs 3: P¼ 0.0161.
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tional polymorphism classically studied. The T allele of this SNP
appeared signiﬁcantly more frequent in cases than in controls
(68.4% vs 61.3%, P¼ 0.021). Signiﬁcant ﬁndings were also found
when we assumed an additive model (OR¼ 1.38, 95% CI:
[1.05e1.82], P¼ 0.020), as well as a recessive one (ORTT vs
CTþCC¼ 1.52, 95% CI: [1.05e2.19], P¼ 0.026). However, the signiﬁ-
cance of these results did not survive correction for multiple
testing.
A more signiﬁcant ﬁnding was observed with rs143384, which
demonstrated association at both allelic and genotypic levels. The
major allele (T) of this marker was overrepresented in cases (65.9%
vs 55.9%, P¼ 0.002). Carriers of the TT genotype had a 2.23-fold
higher risk of developing CDH than those with the CC genotype
(ORTT vs CC¼ 2.23, 95% CI: [1.30e3.84], P¼ 0.004). The disease risk
associated with the CT genotype was not signiﬁcantly increased
(ORCT vs CC¼ 1.43, 95% CI: [0.85e2.43], P¼ 0.182), but a linear trend
was nevertheless observed (Ptrend¼ 0.002). Thus, under an additive
genetic model, each additional copy of the T allele increased by 1.51
the disease risk (OR¼ 1.51, 95% CI: [1.16e1.95], P¼ 0.002). Signiﬁ-
cant results were also obtained when assuming a recessive model
and carriers of the TT genotype were found to have a 1.71-fold
higher risk of developing CDH than carriers of the other genotypes
(ORTT vs CTþCC¼ 1.71, 95% CI: [1.18e2.48], P¼ 0.005). All these
ﬁndings remained signiﬁcant after adjustment for the number of
markers genotyped and ofmodels tested. Moreover, for thatmarker
(T allele frequency¼ 65.9%), the study power reached 85.2% under
an additive model (OR¼ 1.51) and 85.8% under a recessive one
(OR¼ 1.71).Table II
Results of the association study between CDH and the three SNPs selected in GDF5
SNP Cases
rs224334 Genotype AA 0 0.0%
GA 14 5.9%
GG 225 94.1%
Allele A 14 2.9%
G 464 97.1%
rs143384 Genotype TT 106 44.4%
CT 103 43.1%
CC 30 12.6%
Assumption of a recessive model:
Assumption of an additive model:
Allele T 315 65.9%
C 163 34.1%
rs143383 Genotype TT 111 46.4%
CT 105 43.9%
CC 23 9.6%
Assumption of a recessive model:
Assumption of an additive model:
Allele T 327 68.4%
C 151 31.6%Haplotype-based association study
Analysis of LD pattern revealed that rs143384 and rs143383
were in strong LD in our sample, with a pairwise r2 of 0.84.
Haplotype inference deﬁned three different haplotypes in our
sample among the four plausible ones. Haplotype analysis also
revealed a signiﬁcant association; the frequency of the haplotype
carrying the susceptibility alleles of these SNPs being signiﬁcantly
increased among CDH patients (TT haplotype: 65.9% vs 55.9%,
OR¼ 1.53, 95% CI: [1.18e1.98], P¼ 0.002). It should be noted that
the T allele of rs143384 was only present in this haplotype, which
implied that the TT haplotype frequency was similar to the T allele
frequency of rs143384. Haplotype analysis did not add to the
ﬁndings as the P-values remained unchanged.
Discussion
The present study investigates for the ﬁrst time the association
between polymorphisms of GDF5 and CDH in Caucasians, and
supports that this gene may be involved in the aetiology and the
pathogenesis of this disease.
The case-control study we carried out revealed a signiﬁcant
association with two of the three polymorphisms captured in this
gene.However, only the resultsof rs143384remainedsigniﬁcantafter
correction for multiple testing. The major allele (T) of this poly-
morphism was strongly associated with CDH, the smallest P-values
being obtained under an additive model (OR¼ 1.51, P¼ 0.002) and
a recessive model (OR¼ 1.71, P¼ 0.005). Power calculations showed
that our study achieved sufﬁcient power to detect these associations,
under both models.
The polymorphism rs143384 was not analysed by Dai et al. in
the only association study that has so far investigated the role of
GDF5 in CDH11. This study, based on 338 patients and 622 controls,
examined the association between congenital dysplasia of the hip
and the functional polymorphism previously associated with hip
osteoarthritis (rs143383) in a Han Chinese population. This poly-
morphism belonged to the set of tagSNPs we studied, and, inter-
estingly, provided less signiﬁcant ﬁndings than those obtainedwith
rs143384. This difference in magnitude of effect could not be
explained by sampling variability as, in our study, the associations
of rs143383 and rs148334 were examined in the same number of
individuals. However, the strength of the association we observed
with rs143383 was consistent with that reported by Dai et al.11. ForControls OR [95% CI] P
0 0.0% e
21 8.8% 0.65 [0.32e1.30] 0.222
218 91.2% 1.00
21 4.4% 0.66 [0.33e1.31] 0.231
457 95.6% 1.00
76 31.8% 2.23 [1.30e3.84] 0.004
115 48.1% 1.43 [0.85e2.43] 0.182
48 20.1% 1.00
1.71 [1.18e2.48] 0.005
1.51 [1.16e1.95] 0.002
267 55.9% 1.53 [1.18e1.98] 0.002
211 44.1% 1.00
87 36.4% 1.83 [1.00e3.34] 0.049
119 49.8% 1.27 [0.70e2.29] 0.436
33 13.8% 1.00
1.52 [1.05e2.19] 0.026
1.38 [1.05e1.82] 0.020
293 61.3% 1.37 [1.05e1.79] 0.021
185 38.7% 1.00
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study and 1.41 in the Chinese study.
The major strengths of our study were a more complete analysis
of the gene and the accuracy of statistical methods. Our study is the
ﬁrst that evaluated the association between CDH andmultiple SNPs
in GDF5, previous studies being usually limited to the analysis of
rs143383. It should be kept in mind that the most signiﬁcant
ﬁndings in our study were obtained with rs143384, another SNP of
the 50-UTR region of GDF5. Further investigations are therefore
needed to better elucidate the role of this polymorphism in CDH
pathogenesis. Regarding LD, rs143384 and rs143383 correlated
with r2¼ 0.91 in Asian populations and r2¼ 0.75 in European
populations according to HapMap data, whereas the r2 value
observed in our population was 0.84.
GDF5 is a gene involved in developmental processes including
chondrogenesis, skeleto-genesis and joint formation22. Mutations
in this gene have been associated with a broad spectrum of skeletal
disorders including limb malformations23, what conﬁrms its role in
skeletal development. It has also been shown that the encoded
proteinwas able to induce articular cartilage and bone formation in
vitro and in vivo40. In vivo studies have also highlighted that GDF5 is
present in the cartilage of human adults13 and expressed in tissues
where joints will appear later during development. Therefore,
reduction in GDF5 expression might affect acetabulummorphology
and/or might lead to developmental deﬁciency of the ligaments
and the capsule in hip joints, therefore contributing to CDH.
GDF5 has received extensive attention in the recent literature. In
2007, Miyamoto et al. reported that this gene could be a suscepti-
bility gene for hip osteoarthritis12. Based on a case-control study
design, these authors noticed that a functional SNP (rs143383) of
the 50-UTR region of GDF5was associated with hip osteoarthritis in
two independent Asian populations (Japanese and Han Chinese).
The T allele of this polymorphism was overrepresented in patients
(83.6% vs 74.0%), with an OR of 1.79 (95% CI: [1.53e2.09],
P¼ 1.8 1013). Through in vitro functional studies, they also
demonstrated that this allele mediated a moderate but signiﬁcant
decrease of GDF5 promoter activity in chondrogenic and non-
chondrogenic cell lines.
The number of papers published on GDF5 has since increased
tremendously. The association observed by Miyamoto et al. has
subsequently been widely replicated in other ethnic groups13e15
and conﬁrmed by meta-analyses16,17. This association between
rs143383 and osteoarthritis constitutes one of the most robust
genetic associations observed in that disease. Its plausibility is also
supported by recent in vivo experiments. Southam et al.13 thus
demonstrated that rs143383 inﬂuenced GDF5 allelic expression in
vivo. Their experiment, based on RNA extracted from the cartilage
of osteoarthritis patients undergoing total hip or knee replacement,
revealed that the T allele led to an average 12% reduction in
expression compared with the C allele. More recently, Egli et al.18
showed that this differential allelic expression was not restricted
to cartilage and was also present in other joint tissues (synovium
and ligaments). The authors also highlighted the complexity of the
regulation of GDF5 expression, and showed that the effect of
rs143383 was inﬂuenced by rs143384. They notably observed that
the T allele of rs143383 reduced GDF5 allelic expression only when
it was carried in cis with the T allele of rs143384 (haplotype TT).
Combination of all these data makes GDF5 an interesting suscep-
tibility gene for osteoarthritis.
Beyond osteoarthritis, genetic variations in the GDF5 locus have
been reported to be involved in the pathogenesis of rheumatoid
arthritis41 and to inﬂuence human height, hip axis length and
fracture risk in the elderly14,42. Regarding CDH, Dai et al. were the
ﬁrst to study in 2008 the association between rs143383 and
congenital dysplasia of the hip, and to report signiﬁcant results ina Chinese population11. Our study highlights the association
between GDF5 polymorphisms and CDH in another ethnic group
(i.e., Caucasians). Moreover, it reveals another SNP of interest that
has been shown to inﬂuence the functional effect of rs143383 in
osteoarthritis.
Our study provides useful data on the genetic determinism of
CDH as, until recently, little was known about the genetic factors
involved in that disease. Before the study of Dai et al. in 2008, only
ﬁve genetic-based association studies and one linkage analysis had
been carried out on CDH11,31,43e46. Most of them reported negative
ﬁndings. A linkage study conducted in a Japanese family with hip
osteoarthritis associated with acetabular dysplasia revealed
a region of interest on chromosome 13 in position 13q2247, but no
gene has been reported to date. Three linkage analysis studies have
also been performed on canine pedigrees. They have pointed out
various loci, but no susceptibility gene has yet been identiﬁed
in dogs48e50.
In conclusion, this study reports, for the ﬁrst time, the associa-
tion between GDF5 polymorphisms and CDH in Caucasians, and
therefore supports the involvement of this gene in CDH patho-
genesis. This study also points out another polymorphism of
interest that requires further investigation. Identiﬁcation of genetic
factors should enable better understanding of the pathogenesis of
that complex disease and avoid late diagnosis and treatment. It
should also promote earlier identiﬁcation of patients at risk of
developing hip osteoarthritis.Author contributions
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